8-KCorporate ChangesExhibits & Filings

CME GROUP INC. 8-K Report, Bylaw Amendment (Feb 13, 2017)

Filed February 13, 2017For Securities:CME

Summary

CME Group Inc. filed an 8-K on February 13, 2017, reporting amendments to its Bylaws, effective February 8, 2017. The most significant change is the implementation of "proxy access," which allows certain long-term shareholders to nominate director candidates and include them in the company's proxy materials. This provision will be effective for the 2018 annual meeting. The amendments also include clarifications and refinements to existing advance notice provisions for director nominations, as well as updates to the requirements for director nominee questionnaires and representations. Additionally, the voting standard for Class B directors was clarified, and other technical changes were made to the Bylaws. These updates aim to enhance shareholder engagement and corporate governance.

Key Highlights

  • 1CME Group Inc. amended and restated its Bylaws on February 8, 2017.
  • 2The primary amendment introduces 'proxy access' for shareholders.
  • 3Proxy access allows shareholders owning 3% or more of stock for at least three years to nominate director candidates.
  • 4Nominated candidates can be included in CME's proxy materials.
  • 5Proxy access will be available starting with the 2018 annual shareholder meeting.
  • 6Bylaws were updated with clarifications to advance notice provisions for director nominations.
  • 7Technical and conforming changes were made to other bylaw sections, including clarification of the voting standard for Class B directors.

Frequently Asked Questions